From First Indication to Scalable Platform: Evolving Minimally Invasive Retinal Repair into a Versatile Ocular Drug Delivery Engine
12:00 pm - Wednesday 28th January 2026
- Minimally invasive retinal detachment to validate the delivery approach in a high-unmet-need, procedure-driven setting and de-risk broader platform development.
- How early clinical and procedural experience in retinal repair generated critical insights into precision, safety, and tissue interaction
- Evolving delivery systems to support adaptability across payload types, indications, and routes of administration without compromising procedural simplicity.